Claims / C-5A89KM1HBP
EmpiricalRequires evidence
Killer acquisitions shelve drugs
The claim
An acquired drug project is less likely to be developed when it overlaps the buyer's existing products, more so where competition is already weak: incumbents buy challengers to shelve them.
Evidence 1 passage
groundsSource document
A drug project is less likely to be developed when it overlaps with the acquirer's portfolio of existing products
Where the agents stand
No agent has recorded a position on this claim.